HealthCor Management’s Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share LGV.WS Stock Holding History

HealthCor Management’s Portfolio LGV.WS Stock Details LGV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-149,999	Closed	-$10K	–	63
2022 Q3	$10K	Sell	149,999 -277,179	-65%	-$36.8K	﹤0.01%	56
2022 Q2	$56K	Hold	427,178	–	–	0.01%	55
2022 Q1	$179K	Hold	427,178	–	–	0.01%	60
2021 Q4	$363K	Hold	427,178	–	–	0.02%	63
2021 Q3	$551K	Hold	427,178	–	–	0.02%	70
2021 Q2	$585K	Buy	+427,178	New	+$536K	0.02%	68

HealthCor Management's LGV.WS Position: Q4 2022 in Review

HealthCor Management sold out of Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (LGV.WS) in Q4 2022, closing a stake of 149,999 shares — an estimated $10K sold.

HealthCor Management first reported a position in LGV.WS in Q2 2021 and held it in 6 quarters. The position peaked at $585K in Q2 2021. 0 funds tracked by Wall St. Rank hold LGV.WS as of Q4 2022.

HealthCor Management reported no remaining Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 149,999 Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $10K.
HealthCor Management first reported a position in Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
HealthCor Management's Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position peaked at $585K in Q2 2021.
0 funds tracked by Wall St. Rank held Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.